Steve Gorlin's most recent trade in BioVie Inc was a trade of 75,680 Common Stock done at an average price of $1.7 . Disclosure was reported to the exchange on Nov. 9, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioVie Inc | Steve Gorlin | Director | Sale of securities on an exchange or to another person at price $ 1.69 per share. | 09 Nov 2023 | 75,680 | 46,358 (0%) | 1% | 1.7 | 127,899 | Common Stock |
| BioVie Inc | Steve Gorlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2023 | 46,358 | 122,038 (2%) | 0% | 0 | Common Stock | |
| BioVie Inc | Steve Gorlin | Director | Sale of securities on an exchange or to another person at price $ 3.05 per share. | 05 Sep 2023 | 8,560 | 75,680 (1%) | 0% | 3.1 | 26,108 | Common Stock |
| BioVie Inc | Steve Gorlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2022 | 34,240 | 84,240 (1%) | 0% | 0 | COMMON STOCK | |
| BioVie Inc | Steve Gorlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 122,250 | 122,250 | - | - | Stock Option (right to buy) |